Books, Original Papers & Review Papers- UCHIDA Yasuo -
number of results to view: what to display: sort:
[B]:Books [O]:Original Papers [R]:Review Papers
total:77
[2020]
1.[O] Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood-brain barrier.[J Cereb Blood Flow Metab,40(2),(2020),420-436]Uchida Y, Hoshi Y, Tachikawa M, Ohtsuki S, Couraud PO, Suzuki T, Terasaki T
10.1177/0271678X18822801
2.[O] Abundant expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1 and xCT transporters in blood-arachnoid barrier of pig, and polarized localizations at CSF- and blood-facing plasma membranes.[Drug Metab Dispos,48(2),(2020),135-145]Uchida Y, Goto R, Takeuchi H, Łuczak M, Usui T, Tachikawa M, Terasaki T
10.1124/dmd.119.089516
3.[B] Blood-arachnoid barrier as a dynamic physiological and pharmacological interface between cerebrospinal fluid and blood.[Springer, 印刷中,(2020)]Y Uchida, R Goto, T Usui, M Tachikawa and T Terasaki
4.[O] Distinct roles of ezrin, radixin and moesin in maintaining the plasma membrane localizations and functions of human blood-brain barrier transporters.[J Cereb Blood Flow Metab,Accepted for publication,(2020)]Hoshi Y, Uchida Y, Kuroda T, Tachikawa M, Couraud PO, Suzuki T, Terasaki T
10.1177/0271678X19868880
[2019]
5.[R] 中枢疾患時の血液脳関門P糖タンパク質の機能変動機構の解明と中枢関門創薬への新展開.[医学のあゆみ,271(1), (2019), 104-111]内田康雄、臼井拓也、寺崎哲也
6.[O] Amyloid beta(25-35) impairs docosahexaenoic acid efflux by down-regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells.[J Neurochem,150(4),(2019),385-401]Ochiai Y, Uchida Y, Tachikawa M, Couraud PO, Terasaki T
10.1111/jnc.14722
7.[O] Involvement of claudin-11 in disruption of blood-brain, -spinal cord and -arachnoid barriers in multiple sclerosis.[Mol Neurobiol,56(3),(2019),2039-2056]Y Uchida, T Sumiya, M Tachikawa, T Yamakawa, S Murata, Y Yagi, K Sato, A Stephan, K Ito, S Ohtsuki, PO Couraud, T Suzuki, T Terasaki
10.1007/s12035-018-1207-5
8.[R] Uniprotデータベース.[ファルマシア,55(4), (2019), 335]内田康雄
9.[R] 次世代型定量プロテオミクスに基づく中枢関門の新規密着結合 分子の同定および多発性硬化症の中枢関門破綻への関与.[ファルマシア,55(4), (2019), 320-324]内田康雄
10.[O] Selective Protein Expression Changes of Leukocyte-Migration-Associated Cluster of Differentiation Antigens at the Blood-Brain Barrier in a Lipopolysaccharide-Induced Systemic Inflammation Mouse Model without Alteration of Transporters.[Biol Pharm Bull,42(6),(2019),944-953]Sato K, Tachikawa M, Watanabe M, Uchida Y, Terasaki T
10.1248/bpb.b18-00939
11.[O] Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper.[Clin Pharmacol Ther,106(3),(2019),525-543]Prasad B, Achour B, Artursson P, Hop CECA, Lai Y, Smith PC, Barber J, Wisniewski JR, Spellman D, Uchida Y, Zientek MA, Unadkat JD, Rostami-Hodjegan A
10.1002/cpt.1537
12.[O] Abundant expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1 and xCT transporters in blood-arachnoid barrier of pig, and polarized localizations at CSF- and blood-facing plasma membranes.[J Neurochem,Accepted for publication,(2019)]Yasuo Uchida, Ryohei Goto, Hina Takeuchi, Magdalena Łuczak, Takuya Usui, Masanori Tachikawa and Tetsuya Terasaki
13.[O] Quantification of ENT1 and ENT2 proteins at the placental barrier and contribution of these transporters to ribavirin uptake.[J Pharm Sci,(2019),in press-]Nishimura T, Sano Y, Takahashi Y, Noguchi S, Uchida Y, Takagi A, TanakaT, Katakura S, Nakashima E, Tachikawa M, Maruyama T, Terasaki T, Tomi M
14.[R] 輸送分子夾雑系の再構築に基づくヒト血液脳関門の薬物輸送システムの解明.[CMCB NEWS LETTER, (2019)]内田康雄
[2018]
15.[O] High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.[Mol Pharm.,15(1),(2018),127-140]Akazawa T, Uchida Y, Miyauchi E, Tachikawa M, Ohtsuki S, Terasaki T
10.1021/acs.molpharmaceut.7b00772
16.[O] ATP-binding cassette transporter A subfamily 8 is a sinusoidal efflux transporter for cholesterol and taurocholate in mouse and human liver.[Mol Pharm.,15(2),(2018),343-355]Sasaki K, Tachikawa M, Uchida Y, Hirano S, Kadowaki F, Watanabe M, Ohtsuki S, Terasaki T
10.1021/acs.molpharmaceut.7b00679
17.[O] Drug clearance from cerebrospinal fluid mediated by organic anion transporters 1 (Slc22a6) and 3 (Slc22a8) at arachnoid membrane of rats.[Mol Pharm.,15(3),(2018),911-922]Zhang Z, Tachikawa M, Uchida Y, Terasaki T
10.1021/acs.molpharmaceut.7b00852
18.[O] Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics..[PloS one,13(3),(2018),e0193799-]Miyauchi E, Furuta T, Ohtsuki S, Tachikawa M, Uchida Y, Sabit H, Obuchi W, Baba T, Watanabe M, Terasaki T, Nakada M
10.1371/journal.pone.0193799
http://www.ncbi.nlm.nih.gov/pubmed/29513714
19.[R] SWATH-MS法って何?優れた定量精度・感度・網羅性を兼ね備えた次世代型定量プロテオミクス.[薬剤学「最近のトピックス」,78(5), (2018), 228-234]内田康雄
[2017]
20.[O] Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration.[JOURNAL OF PHARMACEUTICAL SCIENCES,106(9),(2017),2499-2508]Takayuki Miura, Masanori Tachikawa, Hideo Ohtsuka, Koji Fukase, Shun Nakayama, Naoaki Sakata, Fuyuhiko Motoi, Takeshi Naitoh, Yu Katayose, Yasuo Uchida, Sumio Ohtsuki, Tetsuya Terasaki, Michiaki Unno
10.1016/j.xphs.2017.02.018
http://www.ncbi.nlm.nih.gov/pubmed/28249806 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000417339900040&DestApp=WOS
Page: [1] [2] [3] [4] [next]
BackTop
copyright(c)2005 Tohoku University